CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

How Data Science is Revolutionizing Genomics

How Data Science is Revolutionizing...

Human-specific Proteins Uncovered by Exploring Genetic Uncharted Territory

Human-specific Proteins Uncovered by...

A Broader Perspective of Genomics

A Broader Perspective of Genomics

The Future Of Genomics In Theory-Focused Approaches

The Future Of Genomics In...

Role of Human Genomic Data in Future

Role of Human Genomic Data in Future

Essentiality of Single-cell Genomics Technology

Essentiality of Single-cell Genomics...

Tactics to Handle Genomic Data

Tactics to Handle Genomic Data

Benefits of Advanced Genomic Testing

Benefits of Advanced Genomic Testing

How Data Science is Revolutionizing Genomics

How Data Science is Revolutionizing...

Human-specific Proteins Uncovered by Exploring Genetic Uncharted Territory

Human-specific Proteins Uncovered by...

A Broader Perspective of Genomics

A Broader Perspective of Genomics

The Future Of Genomics In Theory-Focused Approaches

The Future Of Genomics In...

Role of Human Genomic Data in Future

Role of Human Genomic Data in Future

Essentiality of Single-cell Genomics Technology

Essentiality of Single-cell Genomics...

Tactics to Handle Genomic Data

Tactics to Handle Genomic Data

Benefits of Advanced Genomic Testing

Benefits of Advanced Genomic Testing

Benefits of Genomics-driven Drug Discovery

Life Sciences Review | Monday, August 30, 2021
Tweet

Advances in genotyping technologies have yielded several studies concerning the relationships between the genome and an extensive range of traits.


FREMONT, CA: Genome-wide association studies have found several disease-susceptibility genes. As knowledge of gene-disease connections accumulates, it is increasingly becoming essential to translate this knowledge into clinical practice. This hurdle involves finding effective drug targets and estimating their side effects, which often results in promising clinical trials' failure. Here is a review of recent advances and future perspectives in genetics-led drug discovery, focusing on drug repurposing and the use of multifaceted omics data.


Despite the drastic effort and substantial resources dedicated to biomedical research, only some promising academic discoveries have resulted in new treatments. Such a gap between research and clinical practice is a hurdle for the whole field of biomedical research and is often referred to as the valley of death. One of the reasons for this gap is the biological differences between humans and other model organisms.


Validation in other organisms, like mice, does not necessarily mean that the outcomes will be replicated in humans. Investigating the effect of human genetic variation on phenotypes can offer insight into pathophysiology in the human body, which will result in the discovery of true drug targets.


One effective method for improving clinical practice is drug repurposing. Drug repurposing is a method for finding new indications for existing approved drugs or drugs in clinical trials. If the drug's safety has been confirmed in early-stage clinical trials for its original intention, repurposing existing drugs needs less cost for testing the safety than developing and deploying novel drugs. The data on disease-susceptibility genes for drug repurposing has been exploited. The use of existing drug classification systems is a promising method to systematically assess gene–drug associations for several diseases.


Given the requirement for novel drug development, prioritizing genes as therapeutic targets is a decisive step. These leading studies demonstrate that insight into disease-susceptibility genes is a potential resource for more efficient drug discovery. The coupling of other biological data is also vital to drug discovery.


See Also :Towards a New World Order


Weekly Brief

loading
Top 10 Genomics Solutions Companies in Europe/UK – 2022
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/benefits-of-genomicsdriven-drug-discovery-nwid-350.html